Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin-6 receptor-alpha inhibition with tocilizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin-6 receptor-alpha inhibition with tocilizumab

Published:2015-09-28 Issue:2 Volume:10 Page:183-194
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Lee Janet S.¹,Chapman M. John²,Piraino Paolo³,Lamerz Jens⁴,Schindler Thomas⁴,Cutler Paul⁴,Dernick Gregor⁴

Affiliation:

1. Roche; Nutley NJ USA

2. INSERM Dyslipidemia and Atherosclerosis Research Unit; Pitié-Salpêtrière University Hospital; Paris France

3. Pvalue Research S.R.L; Piacenza Italy

4. Roche Pharmaceutical Research and Early Development; Roche Innovation Center Basel; F. Hoffmann-La Roche AG; Basel Switzerland

Funder

F. Hoffman-La Roche

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.201500036/fullpdf

Reference59 articles.

1. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review;Danesh;PLoS Med,2008

2. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis;Hingorani;Lancet,2012

3. An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy;Rao;Arthritis Rheumatol.,2015

4. Tocilizumab in rheumatoid arthritis: a case study of safety evaluations of a large postmarketing data set from multiple data sources;Curtis;Semin. Arthritis Rheum.,2015

5. The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study;Ljung;Arthritis Res. Ther.,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein(a): Emerging insights and therapeutics;American Journal of Preventive Cardiology;2024-06

2. Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?;Atherosclerosis Plus;2023-12

3. Interleukin-6 Inhibition and Lipoprotein(a): An Association Requiring More Research;Current Pharmaceutical Design;2023-08

4. Tocilizumab‐related hypertriglyceridemia is independent of key molecules regulating lipid metabolism;European Journal of Clinical Investigation;2023-04-20

5. Impact of the Uncoupling Protein 1 on Cardiovascular Risk in Patients with Rheumatoid Arthritis;Cells;2021-05-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3